NeuroBo Pharmaceuticals, Inc
Why Robinhood?
You can watch NRBO and buy or sell other stocks, ETFs, and their options commission-free!About NRBO
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
NRBO Key Statistics
Stock Snapshot
NeuroBo Pharmaceuticals, Inc(NRBO) stock is priced at $8.18, giving the company a market capitalization of 18.89M. It carries a P/E multiple of -0.15.
On 2026-05-07, NeuroBo Pharmaceuticals, Inc(NRBO) stock opened at —, reached a high of —, and a low of —.
The NeuroBo Pharmaceuticals, Inc(NRBO)'s current trading volume is 0, compared to an average daily volume of 93.62K.
In the last year, NeuroBo Pharmaceuticals, Inc(NRBO) shares hit a 52-week high of $19.03 and a 52-week low of $1.17.
In the last year, NeuroBo Pharmaceuticals, Inc(NRBO) shares hit a 52-week high of $19.03 and a 52-week low of $1.17.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.